| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |